Category: Covid-19
-
Communicable disease threats report, 21–27 April 2024, week 17
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 21–27 April 2024 and includes updates on respiratory virus epidemiology in the EU/EEA, West Nile virus, SARS-CoV-2 variant classification and Cholera.
-
Weekly respiratory virus update, week 16, April 2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
-
Weekly respiratory virus update, week 15, April 2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
-
Data on COVID-19 vaccination in the EU/EEA
This downloadable data file contains information on COVID-19 vaccination in the EU/EEA since September 2023.
-
Surveillance of COVID-19 in long-term care facilities in the EU/EEA 2021-2023
This report collects all COVID-19 long-term care facilities (LTCF) data reported to ECDC from 2021 and concludes the EU/EEA LTCF COVID-19 specific surveillance data collection from 2021-2023.
-
Weekly respiratory virus update, week 14, April 2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels.
-
Interim COVID-19 vaccination coverage in the EU/EEA during the 2023–24 season campaigns
This report presents an interim description of COVID-19 vaccine coverage in the EU/EEA between 1 September 2023 and 15 April 2024.
-
Weekly respiratory virus update, week 17, April 2024
Influenza, SARS-CoV-2 and RSV activity in EU/EEA Member States continue to decrease or remain stable at low levels. Cases, including severe infections, can still occur and it therefore remains essential to continue testing patients presenting with severe acute respiratory symptoms in order to guide treatment and inform epidemiological assessments.
-
Communicable disease threats report, 28 April – 4 May 2024, week 18
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 28 April – 4 May 2024 and includes updates on cholera, MERS-CoV, SARS-CoV-2, an overview of respiratory virus epidemiology in the EU/EEA, highly pathogenic avian influenza A(H5N1) in cattle and a related human case, Crimean-Congo haemorrhagic fever, and Lassa fever.
-
Communicable disease threats report, 18-25 May 2024, week 21
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 18-25 May 2024 and includes updates on respiratory virus epidemiology in the EU/EEA, influenza, avian influenza, and cholera.